Alignment Healthcare Inc (NASDAQ:ALHC) currently has a daily average trading volume of 1.63M but it saw 3322973 shares traded in last market. With a market cap of 2.29B USD, the company’s current market price of $11.95 came rising about 7.75 while comparing to the previous closing price of $11.09. In past 52 weeks, the stock remained buoying in the range of price level as high as $14.25 and as low as $4.46. In the recent trading on the day, stock has struck highest price mark of $11.37 while lowest mark touched by it was $12.24.
Taking a look at 20-day trading activity of Alignment Healthcare Inc (ALHC) gives us an average price of $12.40, while its current price level is -16.14% below from 52-week high level whereas it is 167.94% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $11.69 while that of 200 days or SMA-200 reads an average of $8.28. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.15% during that period while stretching the period over a month that decreases to 6.00%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.00 which implies that the stock is in neutral territory.
BofA Securities upgraded its recommendation for the stock as a “Buy” from “Neutral” on May 30, 2024 while assigning a price target range of $7.75-$11. Robert W. Baird also issued its recommendations for the stock as it initiated the price target for the stock is $10.
Over the week, ALHC’s stock price is moving -6.49% down while it is 11.06% when we observe its performance for the past one month. Year-to-date it is 38.79% up and over the past year, the stock is showing an upside performance of 78.62%.
Currently, Alignment Healthcare Inc’s total number of outstanding shares is 188.95M. Company’s return on investment (ROI) stands at -43.27% and return on equity (ROE) at -95.13%. Stock’s beta reads 1.41. Stock has a price to book (P/B) ratio of 19.99 while price to sale or P/S ratio amounts to 0.93. Its return on asset (ROA) is -19.71% on average.